Home/Filings/3/0000899243-23-004342
3//SEC Filing

Longitude Prime Partners, LLC 3

Accession 0000899243-23-004342

CIK 0001831828other

Filed

Feb 7, 7:00 PM ET

Accepted

Feb 8, 7:21 PM ET

Size

7.1 KB

Accession

0000899243-23-004342

Insider Transaction Report

Form 3
Period: 2023-02-06
Holdings
  • Class A Common Stock

    (indirect: Held by Longitude Prime Fund, L.P.)
    1,714,285
Holdings
  • Class A Common Stock

    (indirect: Held by Longitude Prime Fund, L.P.)
    1,714,285
Footnotes (2)
  • [F1]Not included on this Form 3 are 3,429,927 shares of Class A Common Stock held by Longitude Venture Partners IV, L.P ("LVP IV"). LVP IV, Longitude Capital Partners IV, LLC ("LCP IV"), Patrick G. Enright and Juliet Tammenoms Bakker have separately filed a Form 4 in connection with the acquisition of the shares of Class A Common Stock described in this Form.
  • [F2]The securities are held directly by Longitude Prime Fund, L.P. ("LPF"). Longitude Prime Partners, LLC ("LPP"), the general partner of LPF, may be deemed to have voting and investment power with respect to the shares held by LPF. Mr. Enright and Ms. Tammenoms Bakker are the managing members of LPP and may be deemed to share voting and dispositive power over the shares held by LPF. LPP and each of Mr. Enright and Ms. Tammenoms Bakker disclaim beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.

Issuer

Vera Therapeutics, Inc.

CIK 0001831828

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001865779

Filing Metadata

Form type
3
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 7:21 PM ET
Size
7.1 KB